Patent ID: 11906529
Assignee: MARSHALL UNIVERSITY RESEARCH CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC G  A  C | IPC A  C  G

Claim 0:
1. A method for screening for a compound useful for treating endometriosis, comprising:
contacting an endometrial cell with an effective amount of a test compound;
detecting an activity level of JARID2 and miR-155 in the endometrial cell in the presence of the test compound; and
comparing the activity level of JARID2 and miR-155 in the presence of the test compound to a control activity level of JARID2 and miR-155 in a non-contacted endometrial cell, wherein the test compound is identified as a compound useful for the treatment of endometriosis if there is a measurable decrease in the activity level of JARID2 and an increase in the activity level of miR-155 in the contacted endometrial cell as compared to the control activity level of JARID2 and miR-155.